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Abstract
Introduction and objectives. Surgical treatment due to brest cancer have an impact on women sexuality. There is a need 
for research about effective indications for sexology consultation in women after such treatment. The aim of this study is 
to determine the indications for sexology consultation in women after surgical treatment for breast cancer.  
Materials and method. We tested 42 women patients diagnosed with breast cancer who had undergone mastectomy 
3 months before the study. 3 months after the surgery the women were surveyed using the Polish version of FSFI assessing 
sexual functioning in women. The result of PL-FSFI were compared with the control group.  
Results. It was found that the mean score of PL-FSFI in the study group 3 months after the surgery was 13.33 points (score 
range: 1.2–31.7; median 8.3 points) with a statistically significant difference in terms of areas: desire, arousal, lubrication and 
orgasm in favour of the control group. The total score of PL-FSFI was significantly lower in women after mastectomy than 
in women after breast-conserving surgery. It has been shown that sexually active women in whom the surgery concerned 
the right breast (on the side of the dominant hand) scored lower on the scale “sexual functioning” of QLQ-BR-23 than 
women with surgery of the left breast, with this difference being statistically significant. There was a statistically significant 
correlation between the baseline performance status on the Zubrod scale and the scales: desire, lubrication and satisfaction 
of PL-FSFI. Living in a small town proved to be statistically significant for predicting a lower risk of sexual dysfunction among 
the surveyed women.  
Conclusions. The women who underwent surgery due to breast cancer had a higher risk of sexual dysfunction compared 
to the general population. Higher risk of sexual dysfunction especially concerns women after mastectomy, those who 
underwent breast surgery on the side of the dominant hand, and those with a worse preoperative overall level of functioning 
of ≥ 1 point on the Zubrod scale. A lower risk of disorders was observed in women living in smaller towns. The above factors 
indicate the advisability for sexology consultation in women with breast cancer.
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INTRODUCTION
Normal sexual activity depends on a complex inter-
relationship among multiple systems, including physiological, 
biochemical, neurological and psychological. Furthermore, 
there are multiple factors associated with the diagnosis and 
treatment of cancer that have an impact on women’s sexuality, 
including the complex psychologic and symptom burden of 
the disease and treatments, especially  surgical treatment 
due to breast cancer.
Breast cancer is the most common malignancy among 
women in Poland. In recent years, according to the National 
Cancer Registry, the number of cases annually have exceeded 
16,500 and increased in the last two decades by about 10,000. 
In Poland, breast cancer is now the most common (excluding 
lung cancer), cause of death by cancer among women (the 
number of deaths – about 5,500 a year) [1, 2]. The disease itself 
as well as its mental and social aftermath can significantly 
affect the quality of a woman’s life [3]. Breast surgery can also 
affect the specific, not only in terms of aesthetics, but also 
the symbolic, area of a  woman’s identification. Especially as 
mastectomy involves stress and sometimes a feeling of shame 
and a loss of worth (i.e., the “half a woman” complex) [4]. In 
a study on the psychosocial consequences of mastectomy, 
analysis of social, professional and sexual health and the 
body image of women plays an important role [5, 6].
Because surgical treatment due to breast cancer has an 
impact on women’s sexuality, there is therefore a need for 
research about effective indications for sexology consultation 
in women after surgical treatment due to breast cancer.
OBJECTIVE
The aim of this study is to determine the indications for 
sexology consultation in women after surgical treatment for 
breast cancer, considering the differences resulting from the 
specificity of surgery, as well as the medical and demographic 
characteristics of the surveyed women.
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MATERIALS AND METHOD
42 women who had undergone surgery from March – 
December 2015 at the Department of Oncology of the the 
Jagiellonian University Medical College in Krakow met the 
inclusion criteria. The study included women aged 18–70, 
with early breast cancer, after surgery, who required adjuvant 
chemotherapy following the surgery, but without evidence of 
a generalised neoplastic process. Women in whom the clinical 
advancement corresponded to the IV degree, i.e., metastatic 
disease, were excluded from the observation. The youngest 
patient was 36 years old and the oldest was 68, with a median 
of 56 years. The majority (59.5%) of respondents were women 
from large cities (population > 300,000) and women with a 
secondary education (35.7%). 64% of the women reported a 
history of additional diseases (hypertension, ischemic heart 
disease, thyroid diseases, pulmonary diseases and diabetes). 
The patients’ body mass index (BMI) was also calculated and 
was within the range: 16.5–38 (median 26.7).
Depending on indications, the studied patients underwent 
one of 4 types of surgery. The most common (33.3%) was 
breast-conserving therapy with sentinel lymph node biopsy 
(BCT + SNB). Other methods of surgery included: breast-
conserving therapy with auxiliary lymph node dissection 
(BCT + ALND) and mastectomy with sentinel lymph node 
biopsy, or with auxiliary lymph node dissection (M + SNB 
or M + ALND). Depending on the technical possibilities and 
extent of the surgery, the women had one scar (removal of the 
tumour and lymphatic system in one operation) or 2 scars. All 
patients included in the study after surgery received adjuvant 
chemotherapy containing anthracyclines in a similar dose 
range and with a similar profile of side-effects.
Due to the fact that the presented study was observational 
in character and was conducted within a limited time 
and in a limited group of patients, a sample size selection 
formula was not applied, thus the observation group was not 
representative of the whole Polish population of the patients 
with breast cancer. This is an important limitation of the 
study. However, due to the diversity of the group in terms 
of features, such as age, place of residence, education, type 
of surgery, and breast size, it was decided to draw general 
conclusions.
The general characteristic of the group is presented in 
Table 1.
In order to determine the indications for sexology 
consultation in the group of women, depending on the 
method of breast cancer treatment, health covariates and 
quality of life, the following questionnaires were used:
1) Female Sexual Function Index in its Polish language 
version (PL-FSFI), used for the screening of sexual 
functioning of women [7, 8]. The researchers obtained 
the written consent of the authors of the Polish version 
for the use of the questionnaire in the study. PL-FSFI 
includes 19 questions concerning the core emotional and 
physiological areas of sexual contact as occurring over the 
preceding 4 weeks. It takes into account 6 domains: desire, 
agitation, lubrication, experiencing orgasm, satisfaction 
with sexual and emotional relationship with a partner, and 
pain during vaginal intercourse. Point values, which make 
up the total score on a scale of 2.0 – 36.0, are assigned to 
individual responses. A score of less than or equal to 27.5 
points indicates a risk of sexual sphere disorders and is an 
indication for sexology consultation.
2) The standardised questionnaire EORTC QLQ-C30 
(version 3.0) for the evaluation of the quality of life in 
cancer patients and its supplement designed for the study 
of women with breast cancer: Quality of Life Questionnaire 
for Breast Cancer (EORTC QLQ-BR23) [9, 10, 11]. The 
researchers obtained written consent for the use of EORTC 
questionnaires.
The patients completed the questionnaires in the 3rd 
month following surgery. Each patient answered additional 
questions on demographic data: education, occupation, place 
of residence, breast size before the surgery (cup size A – E) 
and a subjective evaluation of the appearance of the scars 
after the surgery (possible variants of assessment: good, 
average, bad, I have no opinion). The PL-FSFI was also used 
to survey a randomly selected control group of 25 women 
aged 25–68 years with no prior history of cancer treatment. 
The presented results represent a fragment of a wider research 
project at the Department of Gynaecologic Oncology and 
Department of Oncology of the Jagiellonian University 
Medical College under the title: Subjective body image – 
“Body self” and the level of sexual satisfaction in women 
undergoing gynaecological and oncological surgery. The 
study was approved by the Jagiellonian University Bioethics 
Committee (KBET/96/B/2013).
Statistical analysis was performed using Statistica 12.5. 
Analyses of independent variables were carried out using the 
Mann-Whitney U test and the multiple regression method.
RESULTS
19 of the 42 surveyed women (45%) did not give a complete 
answer or refused to answer the PL-FSFI questionnaire. In 
48% of the cases, the lack of response was associated with a 
lack of sexual contact for various reasons (lack of a partner 
– 16%, “by choice” – 11%, disease – 5%, age – 5%). 52% of the 
women did not give reasons for their refusal. The mean score 
of the PL-FSFI questionnaire in the study group 3 months 
Table 1. The general characteristics of the study group
Statistics
Place of residence Education Comorbid 
internal 
diseases
Type of the surgery Breast Breast size
Large 
City
Small 
Town
Village higher
secon-
dary
voca-
tional
primary
BCT + 
SNB
BCT + 
ALND
M + 
SNB
M + 
ALND
right left
Cup 
A
Cup 
B
Cup 
C
Cup 
D
Cup 
E
Number
(n)
25 8 9 13 15 10 4 27 14 9 10 9 15 27 1 10 16 6 7
% 59.5 19.0 21.4 31.0 35.7 23.8 9.5 64.3 33.3 21.4 23.8 21.4 35.7 64.3 2.5 25.0 40.0 15.0 17.5
BCT + SNB – breast-conserving therapy with sentinel lymph node biopsy
BCT + ALND – breast-conserving therapy with axillary lymph node dissection
M+SNB – mastectomy with sentinel lymph node biopsy
M+ALAND – mastectomy with with axillary lymph node dissection
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after the surgery was 13.33 points (score range: 1.2–31.7; 
median 8.3 points) and it was significantly lower than the 
result of the control group, which was 21.36 points. 
Comparison of the results of the individual scales of PL-FSFI 
with the control group revealed statistically significant 
differences in the areas of: desire, arousal, lubrication, and 
orgasm. In each of these areas women after breast surgery 
scored significantly lower than the control group. There were 
no significant difference in the scales “satisfaction with sexual 
intercourse” and “experiencing pain during vaginal 
intercourse” between the compared groups (Tab. 2).
On comparing the results of the PL-FSFI obtained from 
women after mastectomy and women after breast-conserving 
treatment, it was noted that each time women who underwent 
mastectomy obtained a significantly lower overall score 
than women after breast-conserving treatment. Statistically 
significant differences were also evident in terms of the 
following parameters of sexual functioning: desire, arousal, 
lubrication. There was no difference between the groups of 
women after mastectomy and breast-conserving surgery in 
terms of orgasm, satisfaction with intimate relationships with 
a partner and pain experienced during intercourse. There 
was no relationship between the side of the surgery and the 
results of the PL-FSFI (Tab. 3).
In the QLQ-BR23, 2 items assess sexual functioning (14: 
“To what extent were you interested in sex?” and 15: “to what 
extent were you sexually active?”) and one item assesses 
satisfaction with sexual intercourse (16: “To what extent was 
sex enjoyable for you?”). The overall result of QLQ-BR23 in 
the study group is presented in Table 4.
It has been shown that sexually active women, in whom 
treatment concerned the right breast (the side of the dominant 
hand) scored lower than women after surgery of the left breast 
on the scale “sexual functioning” of QLQ-BR23 (describing 
the degree of interest in sex and sexual activity in the previous 
4 weeks), and this difference was statistically significant. 
However, there were no differences in the satisfaction with 
sexual intercourse (item 16 of QLQ-BR23), depending on the 
type of surgery (Tab. 5).
There were significant correlations between the 
performance status evaluated on the Zubrod scale before 
surgery and the PL-FSFI scales of: desire, lubrication 
and satisfaction, without affecting the scales measuring: 
arousal, orgasm and pain during intercourse. Statistically 
significant correlations between the general performance 
status determined before surgery on the Zubrod scale and 
the overall quality of life measured by QLQ-C30, as well as 
sexual functioning measured by QLQ-BR23 3 months after 
surgery, were also observed (Tab. 6).
This confirms the effectiveness of a simple general clinical 
scale for predicting the risk of decreased life quality and the 
occurrence of sexual functioning disorders in women after 
mastectomy. There was no correlation between the BMI and 
Table 2. Comparison of PL-FSFI results between the group of women 
after surgical treatment for breast cancer and control group
PL-FSFI group n mean SD median min max
Mann-
Whitney 
U Test
total score
study 21 13.33 9.77 8.3 1.2 31.7 p = 
0.0157control 25 21.36 10.30 24.5 3.4 34.4
Desire
study 21 2.01 0.83 1.8 1.2 3.6 p = 
0.0089control 25 2.93 1.28 3.0 1.2 6.0
Arousal
study 21 1.51 1.45 1.2 0.0 4.5 p = 
0.0154control 25 2.92 1.90 3.0 0.0 5.7
Lubrication
study 21 1.91 2.28 0.3 0.0 6.0 p = 
0.0129control 25 3.76 2.15 4.5 0.0 6.0
Orgasm
study 21 1.94 2.08 1.2 0.0 6.0 p = 
0.0247control 25 3.49 2.07 4.0 0.0 6.0
Satisfaction
study 19 3.11 1.72 3.0 0.0 6.0 p = 
0.1906control 25 3.84 1.96 4.4 0.4 6.0
Pain
study 21 3.20 2.76 4.4 0.0 6.0 p = 
0.1421control 25 4.43 2.26 5.6 0.0 6.0
Table 3. Comparison of PL-FSFI results between distinguished groups 
of women after mastectomy (M), breast-conserving treatment (BCT) 
and control group
PL-FSFI surgery n mean
st. 
dev.
Me min max
Kruskal-
Wallis rank 
ANOVA
Total score
BCT 13 14.00 9.54 8.3 4.0 27.6
p = 0.0486M 8 12.25 10.71 10.2 1.2 31.7
control 25 21.36 10.30 24.5 3.4 34.4
Desire
BCT 13 2.05 0.78 2.4 1.2 3.2
p = 0.0308M 8 1.95 0.95 1.5 1.2 3.6
control 25 2.93 1.28 3.0 1.2 6.0
Arousal
BCT 13 1.57 1.41 1.5 0.0 3.9
p = 0.0498M 8 1.43 1.61 0.9 0.0 4.5
control 25 2.92 1.90 3.0 0.0 5.7
Lubrication
BCT 13 2.03 2.38 0.3 0.0 6.0
p = 0.0427M 8 1.73 2.24 0.9 0.0 6.0
control 25 3.76 2.15 4.5 0.0 6.0
Orgasm
BCT 13 2.15 2.00 2.4 0.0 5.2
p = 0.0769M 8 1.60 2.30 0.6 0.0 6.0
control 25 3.49 2.07 4.0 0.0 6.0
Satisfaction
BCT 13 3.06 1.78 3.0 0.0 5.6
p = 0.4068M 6 3.20 1.72 3.2 0.8 6.0
control 25 3.84 1.96 4.4 0.4 6.0
Pain
BCT 13 3.23 2.87 4.4 0.0 6.0
p = 0.3162M 8 3.15 2.77 3.8 0.0 6.0
control 25 4.43 2.26 5.6 0.0 6.0
Table 4. Results of QLQ-BR 23 in the group of women after surgical 
treatment for breast cancer
BR-23 n Mean st. dev. Me min max
body image 42 64.71 31.55 67 0 100
sexual functioning 35 12.80 17.09 0 0 50
satisfaction wih sexual 
intercourse*
12 44.42 21.96 33 0 67
future prospect 42 31.76 32.15 33 0 100
side-effects of systemic treatment 42 41.93 18.20 43 5 78
breast symptoms 42 20.93 21.68 17 0 78
arm symptoms 42 21.98 22.99 17 0 100
hair loss ** 37** 54.84 40.30 33 0 100
* 21 cases not applicable
**3 cases not applicable
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the results of PL-FSFI, QLQ-C30 and QLQ-BR23 in terms of 
the effect on sexual functioning and sexual satisfaction in the 
surveyed women. There was also no correlation between the 
presence of other somatic diseases and the results of the PL-
FSFI or the results of QLQ-C30 and QLQ BR-23 in the study 
group. The patients’ responses describing the dimension 
of “sexual enjoyment” in the QLQ-BR23 were compared 
with the total result of the PL-FSFI. Pearson’s R correlation 
coefficient was used in this analysis. The obtained correlation 
was R = 0.76 at the significance level of p < 0.001, which 
proves the compliance of responses. In order to summarise 
the factors that may affect the final assessment of sexual 
satisfaction in the women surveyed, regression analysis, 
including the type of surgery (BCT vs. mastectomy), place 
of residence, education, and BMI (age-standardised), was 
performed. The model included education, place of residence 
and the assessment of scars following surgery. Other variables 
were not significant in the model. R for the entire model 
was 0.91, R2 – 0.82, the constructed model explains 82% of 
variation, the standard estimation error was 5.21, Fisher’s 
statistic – 5.23, p for the model – < 0.0165 (Tab. 7).
Only one component of the model – living in a small town 
(< 300,000) was statistically significant. On the basis of the 
model, one can say that comparing 2 women with the same 
education and the same age, equally satisfied with the healing 
of scars, place of residence – small town correlates with 
less risk of sexual dysfunction. The influence of individual 
variables on the results of FSFI was also examined, but 
none of them proved to be a statistically significant factor. 
The results of the FSFI for patients after mastectomy were 
compared separately depending on the perception of the scar 
after surgery and the size of the breast that had been removed. 
An ANOVA analysis was performed; also in this case it did 
not yield statistically significant results.
DISCUSSION
Women treated for breast cancer experience a number of 
changes in the areas of psyche, intimacy, sexuality and 
relationships, which often involves a change in body image 
and a disorder in a woman’s natural life cycle. Therefore, 
patients with breast cancer more often than healthy people 
may reveal abnormalities in many areas of life, including 
the area of sexual functioning [12–15]. The data suggest 
that 25% – 90% of women following the surgical treatment 
of breast cancer display mental and sexual disorders. These 
may be somatic disorders, physiological problems, mental 
disorders (depression and anxiety), as well as problems in 
the relationship with a partner [16, 17].
Numerous studies indicate lower sexual activity in women 
with breast cancer compared to the general population [18, 
19]. From the physiological perspective surgery within 
the breast, especially its surgical removal (mastectomy) 
can cause many anatomical and physiological disorders, 
which include: lymphedema of the limb, decreased muscle 
strength, limitation of shoulder mobility, faulty posture. 
All of these abnormalities can cause the sensation of pain, 
difficulty in lifting objects, which often leads to restrictions 
in daily activities [20, 21]. According to data of the American 
Cancer Society, the main problems in the sexual sphere of 
women after mastectomy may be mainly related to more 
psychologically conditioned areas of experiencing arousal 
and orgasm, which is essential to the physiology of sexual 
intercourse [22].
The authors draw attention to the difficulties associated 
with an examination of the sexual sphere of women related 
to crossing the border of intimacy, pointing to the fact 
that most research is limited to asking general questions 
instead of performing detailed analysis of sexual activity 
(arousal, agitation, lubrication, masturbation, satisfaction) 
[16]. The fact that in the current study 45% of the surveyed 
women refused to answer the PL-FSFI questionnaire of 
sexual satisfaction, examining precisely these areas or gave 
incomplete answers, may confirm this observation and 
indirectly indicate difficulties in the area of  sexual life. The 
results of the research conducted by Pytka and Spych [21] 
indicate that 78–88% of women experience decreased sexual 
satisfaction as a negative effect of cancer and therapy. Many 
authors point out that sexual dysfunction concerns mainly 
older women [23–26].
Cancer not only shapes the health of women, but also 
affects the lifestyle and changes their attitude towards their 
own bodies. The diagnosis and initiation of therapy brings 
many changes, both in the physical and mental sphere of a 
Table 5. Sexual functioning in women depending on side of the breast 
surgery
QLQ-BR23, 
scales of 
functioning
Side of 
surgery
n mean SD Me min max
Mann-
Whitney 
U test
Sexual 
functioning
left 22 17.36 18.07 17.00 0.00 50.00 p = 
0.034right 13 5.08 12.39 0.00 0.00 33.00
Satisfaction 
with sexual 
intercourse
left 9 44.33 17.00 33.00 33.00 67.00
NS
right 3 44.67 38.68 67.00 0.00 67.00
* Higher values indicate a better functioning: min: 0, max: 100
Table 6. The higher the general level of impairment before surgery 
(Zubrod scale) – the lower the general quality of life and sexual functioning 
3 months after the breast surgery
Result/Scale
Perfor-
mance 
status  
(PS 0–2)
Zubrod 
Scale
n mean SD Me min max
Mann-
Whitney 
U test
General 
quality of life / 
QLQ-C30)
0 21 67.06 18.16 66.67 33.33 100.00 p = 
0.0141 21 51.98 22.35 50.00 8.33 100.00
Sexual 
functioning / 
QLQ-BR23
0 19 18.37 18.24 17.00 0.00 50.00 p = 
0.0301 16 6.19 13.30 0.00 0.00 33.00
Table 7. Results of regression analysis of the influence of specified 
demographic variables on sexual satisfaction in woman with breast 
cancer
Model components
Regression 
coefficient for b
Standard error
for b
p
Living in a small town 14.8 4.8 0.0148
Living in a village -3.6 2.26 0.2803
Primary education -3.87 4.3 0.3940
Vocational education 10.0 5.8 0.1204
Higher Education -7.7 3.9 0.0844
Assessment of scar -2.5 1.8 0.2166
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woman’s life [21]. Graja et al. [27], in conducting research on 
the quality of life in women treated for breast cancer, have 
shown that a negative body image following surgery can 
trigger fears of relationship breakdown, especially due to an 
impairment in the partners’ sexual relationship.
Arora et  al. [25] in examining the quality of life after 
surgery and systemic treatment, noted that sexual 
functioning was significantly lower in patients undergoing 
systemic therapy, when compared to those patients treated 
only with surgery. This thesis is also consistent with the 
observations of other authors [16, 21]. In the presented 
study, women undergoing surgery due to breast cancer, no 
matter whether it was mastectomy or breast-conserving 
therapy, scored significantly lower on the PL-FSFI scale 
when examining sexual functioning than was the case for 
women in the control group. The mean score of the PL-
FSFI (13.33 points) confirms the advisability for sexology 
consultation in the test group (such a recommendation refers 
to the score ≤ 27.5 points). However, what is interesting in 
the randomly selected control group of healthy women, such 
a decision-making PL-SFSI cut-off point for consultation 
recommendation, as equally for the advisability of sexology 
consultation, does not distinguish the study population and 
the control group. This result is similar to the observations of 
other authors, in which using the FSFI revealed disorders in 
sexual functioning for as many as 67.4% of women prior to 
breast surgery when compared to 82.9% of women following 
the procedure. In this study, however, the cut-off point for 
consultation recommendation was lower – 26.55 points [28].
Thus, the question arises as to whether such a high degree 
of revealed disorders in the FSFI is the result of excessive 
sensitivity to the tool, or perhaps we are witnessing a 
growing number of problems within the sexual sphere for 
the population as a whole? According to other researchers, 
the problems and physiological changes associated with the 
presence and treatment of breast cancer are usually related to 
sexual arousal, experiencing orgasm, desire and satisfaction 
with intimate relationships. These problems can be related 
with the side-effects of chemotherapy, hormonal therapy 
(the induction of premature menopause) and extent of the 
surgery [29].
Also, in our observation the most significant effect of 
cancer translated itself into a reduction in desire, arousal, 
problems with reaching the expected level of vaginal 
lubrication during intercourse and experiencing an orgasm. 
In each of these areas women following breast surgery 
reported greater interference than the control group, as well 
as women following mastectomy who revealed a greater 
severity of problems than women following breast-conserving 
surgery, which is broadly in line with the observations of the 
other authors cited above. The authors point out that the 
disturbances in the sexual sphere of women with breast 
cancer significantly correlate with the reduction of other 
indicators of quality of life [26]. The presented study also 
showed a statistically significant correlation between the 
overall quality of life measured by the QLQ-C30 and sexual 
functioning measured by QLQ-BR23 3 months after the 
surgery. In addition, a correlation between both of these 
indicators with the indicators of overall performance status 
was determined preoperatively using the Zubrod scale, which 
is consistent with the results of other authors confirming the 
correlation between sexual functioning in women following 
breast surgery and their general health [28].
This result also indicates the effectiveness of a simple clinical 
scale measuring the general performance for predicting the 
risk of decreased quality of life and the occurrence of sexual 
functioning disorders in women following mastectomy. The 
observations regarding the relationship of sexual dysfunction 
with age are a source of ambiguous data. Some authors 
have observed that older patients (> 50 years) reveal fewer 
disorders in the sexual sphere and a smaller reduction in 
the quality of life related to the change of body image and 
loss of a sense of being feminine over the course of breast 
cancer oncological treatment than younger women [30]. 
Others, however, have documented better indicators of sexual 
functioning in younger women [31]. The results obtained 
in the current study showed no correlation between sexual 
functioning disorders in the surveyed women and their age; 
they are also in accordance with a range of data available in 
the subject literature [32]. In the analysis of medical variables 
and sexual functioning in women with breast cancer it has 
been demonstrated with statistical significance that women 
following surgery within the right breast had worse indicators 
of sexual functioning than women following surgery within 
the left breast. This observation, given the context that all of 
the surveyed women were right-handed, may indicate that 
the malfunction of the dominant hand after the surgery 
translates itself not only into typically considered, e.g., for 
the purpose of rehabilitation, areas of patient functioning 
(work, self-service), but also into her intimate life. However, 
it is difficult to generalise this conclusion due to the study’s 
lack of a comparative group of left-handed women. There is 
also no subject literature data confirming this observation. 
Other authors emphasise the importance of psychological 
support and sexology intervention in women treated for 
breast cancer [16].
Aanalysis of the premorbid level of patient functioning 
and the current impact of the disease and treatment on 
their relationship with a partner is especially important, 
while the identification and prevention of the symptoms of 
premature menopause, sexual function disorders and body 
image should be an area of  particular interest to clinicians 
[16, 26, 34, 35]. Interesting observations are related to earlier 
social functioning and premorbid sexual relationships in 
women with breast cancer. The authors draw attention to 
the aspect of the premorbid integration of women with 
her natural social environment [36], which shapes their 
subsequent ability to receive adequate support in the course 
of the disease and treatment [16, 33, 34]. In the context of 
these results, the presented observation that women living in 
smaller towns have fewer disturbances in sexual functioning 
and relationship with a partner than residents of large cities, 
may indicate the protective role of smaller, somewhat more 
inclusive communities for the better functioning of women 
equally in the area of  sexual health. This findings might be 
interpreted according to microgenetic theory, which included 
the favorauble effects of environmental factors in symptom 
formation [37], that is in our research the sexual dysfunction 
after surgery due to brest cancer.
CONCLUSIONS
1) Women who underwent surgery due to breast cancer are 
characterised by an increased risk of sexual dysfunction, 
compared to the general population.
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2) The higher risk for sexual dysfunction can affect women 
following mastectomy, compared to women following 
breast-conserving surgery, women following breast surgery 
on the side of the dominant hand, and women qualified 
for treatment with a poorer overall functioning level, that 
is ≥ 1 point on the Zubrod scale.
3) There is a lower risk of the onset of sexual dysfunction 
following breast surgery in women living in smaller towns, 
which can indicate the favourable effects of environmental 
factors in the proper adaptation to cancer.
4) The above combination of factors: the result of PL-FSFI 
≤  27.5 points, mastectomy, surgery on the side of the 
dominant hand, the overall level of functioning, that is 
≥ 1 point on the Zubrod scale, and living in large cities, 
may argue for the necessity for sexology consultation in 
women with breast cancer.
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